Opiant Pharmaceuticals, Inc. (OPNT) News & Overview - Discounting Cash Flows
OPNT
Opiant Pharmaceuticals, Inc.
OPNT (NASDAQ)

OPNT's Business Model

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Sector & Industry Healthcare / Biotechnology
Website https://www.opiant.com
CEO (Chief Executive Officer) Roger Crystal
Number of Employees
IPO date June 4, 2007

OPNT Latest News

Contact
CountryUS
Address233 Wilshirre Boulevard
CitySanta Monica
StateCA
Phone310 598 5410
Zip Code90401
Other Identifiers
CIK0001385508
ISINUS6837501039
CUSIP683750103
Open20.8765
Previous Close20.65
Volume562.8 Thou.
Average Volume72.36 Thou.
Day’s Range20.56 – 20.94
52 Week Range7.34-27.36
MA (50)20.503
MA (200)14.79382
Market Cap108.8 Mil.
Shares Out.5.27 Mil.
Earnings DateAug 03, 2022
Beta
Last Dividend
EPS
PE

Industry Competitors for OPNT

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us